Unum Group

Unum Group (UNM) — Investment Memo

🐂 The Bull Case (Warren's voice)

• The Float Machine: Like any great insurer, Unum's primary gift is the ability to collect premiums upfront. This creates a low-cost source of capital—the float—that allows them to invest for their own benefit before paying claims.
• The B2B Fortress: The moat isn't in the product, but in the integration. Once an insurance provider is baked into a corporation's HR infrastructure and payroll systems, the friction of switching becomes an operational risk. It is a "sticky" B2B relationship that provides a predictable, recurring revenue stream.
• The "Cigar Butt" Potential: If the market overreacts to short-term volatility in the CRE portfolio, we may find the business trading at a significant discount to its book value and liquidation potential.
• Attractive Range: For this to be a Berkshire-grade investment, we would need to see a price that compensates us for the decaying FCF. We aren't buying growth here; we are buying a cash-flow stream at a massive discount. It becomes interesting only when the entry price makes the "diworse-ification" irrelevant.

🐻 The Bear Case (Charlie inverts)

Munger's rule: "Show me where I'll die and I won't go there."

• The Asset Trap (The most likely death): Management has pivoted from insurance underwriting to becoming a mediocre hedge fund. By piling into Commercial Real Estate (Office/Industrial) and Private Equity, they have exposed the float to structural impairment. In a higher-for-longer rate environment with failing office valuations, the "float" could become a liability that eats the equity.
• The Cash-Flow Rot: The divergence between Net Income (NI) and Free Cash Flow (FCF) is a glaring red flag. NI is barely flat, but FCF is crashing at -7.4%. Accounting profits are a polite fiction; cash is the truth. When cash decays faster than earnings, the business is fundamentally leaking value.
• Underwriting Erosion: If the "bureaucratic nightmare" of switching is the only thing keeping customers, the product is no longer competitive. A structural shift toward leaner, digital-first Insurtech could turn their "sticky" moat into a "stagnant" pond.

Most Likely Failure: Asset impairment in the CRE/PE portfolio combined with continuing FCF decay. Timeframe: 2–5 years.

💰 Valuation & Margin of Safety

The provided DCF assumes 3.0% FCF growth, but the historical CAGR is -7.4%. The DCF is likely too optimistic because it assumes the rot stops.

• Intrinsic value estimate: $49.91 per share
• 25% margin of safety entry: $37.43 (conservative)
• 50% margin of safety entry: $24.96 (Buffett's ideal)

Current Status: The stock is fairly valued to expensive relative to its actual cash-flow trajectory. We are paying for a growth rate that the business is currently contradicting.

Verdict: PASS

The business is suffering from "diworse-ification" in its investment portfolio and a rotting cash flow trend. While the B2B moat is real, it does not justify paying a price based on growth that isn't happening. We will wait for a deeply distressed entry point or move on to a business that doesn't bet its float on office buildings.